Clinical Trial Update: An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms [Phase 2]

View source ↗

Summary

Phase 2 open-label study evaluating tamsulosin 0.4 mg for bothersome urinary symptoms in men with lower urinary tract symptoms; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Lower Urinary Tract Symptoms | Phase 2 | Status: COMPLETED | Results posted: 2020-03-27